| pubmed-article:15084936 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15084936 | lifeskim:mentions | umls-concept:C0206510 | lld:lifeskim |
| pubmed-article:15084936 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
| pubmed-article:15084936 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:15084936 | lifeskim:mentions | umls-concept:C2267037 | lld:lifeskim |
| pubmed-article:15084936 | lifeskim:mentions | umls-concept:C0332257 | lld:lifeskim |
| pubmed-article:15084936 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15084936 | pubmed:dateCreated | 2004-4-15 | lld:pubmed |
| pubmed-article:15084936 | pubmed:abstractText | Recurrence of hepatitis C virus (HCV) after liver transplantation is almost universal and decreases both graft and patient survival. Medications that alter nucleic acid metabolism, including some common immunosuppressants used in HCV-infected patients, may affect viral replication. | lld:pubmed |
| pubmed-article:15084936 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15084936 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15084936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15084936 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15084936 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:15084936 | pubmed:issn | 0041-1337 | lld:pubmed |
| pubmed-article:15084936 | pubmed:author | pubmed-author:CarrollKathle... | lld:pubmed |
| pubmed-article:15084936 | pubmed:author | pubmed-author:StanglJason... | lld:pubmed |
| pubmed-article:15084936 | pubmed:author | pubmed-author:IllichmannMit... | lld:pubmed |
| pubmed-article:15084936 | pubmed:author | pubmed-author:StrikerRobert... | lld:pubmed |
| pubmed-article:15084936 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15084936 | pubmed:day | 27 | lld:pubmed |
| pubmed-article:15084936 | pubmed:volume | 77 | lld:pubmed |
| pubmed-article:15084936 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15084936 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15084936 | pubmed:pagination | 562-7 | lld:pubmed |
| pubmed-article:15084936 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:meshHeading | pubmed-meshheading:15084936... | lld:pubmed |
| pubmed-article:15084936 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15084936 | pubmed:articleTitle | Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus. | lld:pubmed |
| pubmed-article:15084936 | pubmed:affiliation | Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA. | lld:pubmed |
| pubmed-article:15084936 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15084936 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15084936 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15084936 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
